Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis

BACKGROUND: Concomitant use of oral azithromycin and inhaled tobramycin occurs in approximately half of US cystic fibrosis (CF) patients. Recent data suggest that this combination may be antagonistic. METHODS: Test the hypothesis that azithromycin reduces the clinical benefits of tobramycin by analy...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cyst Fibros
Hoofdauteurs: Nichols, Dave P., Happoldt, Carrie L., Bratcher, Preston E., Caceres, Silvia M., Chmiel, James F., Malcolm, Kenneth C., Saavedra, Milene T., Saiman, Lisa, Taylor-Cousar, Jennifer L., Nick, Jerry A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5492972/
https://ncbi.nlm.nih.gov/pubmed/28025037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2016.12.003
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items